Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities

Go back to Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
(NASDAQ: PSNL) Delayed: 9.45 +0.03 (0.32%)
Previous Close $9.42    52 Week High
Open $9.47    52 Week Low
Day High $9.87    P/E N/A 
Day Low $9.37    EPS
Volume 1,174,411